Shopping Cart
Remove All
Your shopping cart is currently empty
EA-89 is an effective and selective inhibitor of BRD9, exhibiting antitumor activity. It serves as a target protein ligand for PROTAC and can be utilized in the synthesis of PROTACQA-68.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | EA-89 is an effective and selective inhibitor of BRD9, exhibiting antitumor activity. It serves as a target protein ligand for PROTAC and can be utilized in the synthesis of PROTACQA-68. |
| In vitro | EA-89 (0-3.2 μM; 1-7 days) inhibits cell proliferation and reduces the expression of BRD9, c-MYC, and c-MYB in human leukemia cell lines. |
| Molecular Weight | 594.79 |
| Formula | C31H38N4O4S2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.